Phaseline

Targets › IL1R1

IL1R1 (Interleukin-1 receptor type 1): drug programs, companies and trials

3 programs from 3 companies in 22 trials: 13 Phase 2, 5 Phase 3, 4 Phase 1; Cardiovascular, Oncology, Other; next expected readout Dec 2026.

Receptor for IL1A, IL1B and IL1RN. After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. (UniProt, P14778)

Open in Phaseline: the race on IL1R1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Beijing Tiantan HospitalY-4 tablets
Integrin alpha-IIb/beta-3 inhibitor
PDE3A, ITGB3, ITGA2B, IL1R1Phase 3Ischemic Stroke, Acute; Aneurysmal Subarachnoid Hemorrhage; Acute Ischemic Stroke; Stroke Acute …Dec 2026
Swedish Orphan BiovitrumAnakinra
Interleukin-1 receptor antagonist
IL1R1Phase 3Still's Disease, Juvenile Onset; FMF; Kawasaki Disease; Premature Infants …–
Buzzard Pharmaceuticalsisunakinra
IL-1 receptor 1 inhibitor
IL1R1Phase 2Colorectal Cancer Metastatic; Triple-Negative Breast Cancer (TNBC)Jun 2027

Conditions

Stroke Acute (2) Still's Disease, Juvenile Onset (1) FMF (1) Kawasaki Disease (1) Premature Infants (1) Autoimmune Inner Ear Disease (1) Heart Failure (1) Pancreatic Adenocarcinoma (1) B Cell ALL (1) Dengue (1) Post-Acute COVID-19 Syndrome (1) Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS) (1)

Modalities

protein or peptide (2), small molecule (1)

Companies

Swedish Orphan Biovitrum (1) Beijing Tiantan Hospital (1) Buzzard Pharmaceuticals (1)

Related targets

PDE3A (1) ITGB3 (1) ITGA2B (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.